Muscle magnetic resonance imaging involvement patterns in nemaline myopathies.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
07 2023
Historique:
revised: 05 05 2023
received: 06 12 2022
accepted: 15 05 2023
medline: 19 7 2023
pubmed: 2 6 2023
entrez: 2 6 2023
Statut: ppublish

Résumé

Characterise the diagnostic and prognostic value of muscle MRI patterns as biomarkers in a genetically heterogeneous nemaline myopathy (NM) patient cohort. Modified Mercuri scoring of lower limb MRI in genetically characterised NM patients referred to the highly specialised service for congenital myopathies at Great Ormond Street Hospital. Findings were compared to clinical data and MRI patterns derived from collated published data. Twenty-seven patients with MRI were identified (8 NEB-NM, 13 ACTA1-NM, 6 TPM3-NM). NEB-NM demonstrated sparing of the thigh. ACTA1-NM demonstrated diffuse thigh involvement, notable in the vasti, sartorius and biceps-femoris, with relative adductor and gracilis sparing. TPM3-NM demonstrated diffuse thigh involvement notable in biceps-femoris and adductor magnus with relative rectus femoris, adductor longus and gracilis sparing. In the lower leg, the soleus and tibialis anterior are notably involved in all three genotypes. NEB-NM and ACTA1-NM demonstrated relative gastrocnemii and tibialis posterior sparing, while TPM3-NM showed significantly more tibialis posterior involvement (P =< 0.05). Comparison of involvement patterns with literature datasets highlighted preferential adductor and gracilis sparing in our ACTA1-NM cohort, consistent tibialis posterior involvement in our TPM3-NM cohort and a distinct MRI pattern from those derived from other NM genotypes and congenital myopathies. Greater tibialis anterior involvement correlated with foot drop (P = 0.02). Greater tibialis anterior and extensor hallucis longus involvement correlated with worse mobility (P =< 0.04). This is the widest NM MRI data set described to date; we describe distinct muscle involvement patterns for NEB-NM, ACTA1-NM and TPM3-NM which may have utility as diagnostic and prognostic biomarkers and aid in genetic variant interpretation.

Identifiants

pubmed: 37265148
doi: 10.1002/acn3.51816
pmc: PMC10351659
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1219-1229

Subventions

Organisme : Medical Research Council
ID : MR/S005021/1
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Amyotroph Lateral Scler Frontotemporal Degener. 2022 May;23(3-4):161-175
pubmed: 34151652
Neuromuscul Disord. 2015 May;25(5):392-6
pubmed: 25740301
Lancet Neurol. 2016 Jan;15(1):65-77
pubmed: 26549782
Neuromuscul Disord. 2014 Feb;24(2):117-24
pubmed: 24239060
Neuromuscul Disord. 2020 Jan;30(1):54-58
pubmed: 31866162
J Clin Invest. 2014 Nov;124(11):4693-708
pubmed: 25250574
Neuromuscul Disord. 2013 Aug;23(8):637-46
pubmed: 23810313
Neuromuscul Disord. 2022 Aug;32(8):687-691
pubmed: 35688744
Neuromuscul Disord. 2014 Apr;24(4):325-30
pubmed: 24507666
J Muscle Res Cell Motil. 2019 Jun;40(2):111-126
pubmed: 31228046
AJR Am J Roentgenol. 2008 Jan;190(1):W8-12
pubmed: 18094282
Neuromuscul Disord. 2012 Oct 1;22 Suppl 2:S137-47
pubmed: 22980765
Neuromuscul Disord. 2007 Jun;17(6):433-42
pubmed: 17434307
Eur J Hum Genet. 2013 Nov;21(11):1249-52
pubmed: 23443021
J Neurol. 2020 Apr;267(4):898-912
pubmed: 31776722
Eur J Neurol. 2021 Apr;28(4):1356-1365
pubmed: 33151602
Brain. 2007 Jun;130(Pt 6):1465-76
pubmed: 17525139
Neuromuscul Disord. 2012 Oct 1;22 Suppl 2:S68-84
pubmed: 22980770
Eur J Hum Genet. 2015 Jun;23(6):883-6
pubmed: 25182138
Acta Neuropathol Commun. 2018 Sep 13;6(1):94
pubmed: 30208948
Am J Med Genet A. 2022 Mar;188(3):970-977
pubmed: 34862840
Acta Neuropathol. 2013 Jan;125(1):169-71
pubmed: 23015096
Neurology. 2009 Oct 6;73(14):1159-61
pubmed: 19805734
Br J Radiol. 1990 Dec;63(756):946-50
pubmed: 2268764
Neuromuscul Disord. 2004 Dec;14(12):785-90
pubmed: 15564033
Eur J Neurol. 2018 Jun;25(6):841-847
pubmed: 29498452
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1093-1100
pubmed: 30221479
Neuropathology. 2020 Feb;40(1):104-108
pubmed: 31828823
Can J Neurol Sci. 2015 Sep;42(5):338-40
pubmed: 26348902
Neuromuscul Disord. 2004 Dec;14(12):779-84
pubmed: 15564032
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1071-1081
pubmed: 29735511
Arch Neurol. 2011 Sep;68(9):1171-9
pubmed: 21911697
Brain. 2013 Feb;136(Pt 2):494-507
pubmed: 23378224
J Neurol. 2013 Apr;260(4):969-74
pubmed: 23138982
Neuromuscul Disord. 2016 Jan;26(1):33-40
pubmed: 26573435
Front Neurol. 2018 Jun 26;9:456
pubmed: 29997562
Neurology. 2020 Dec 15;95(24):e3406-e3411
pubmed: 32989108
Mol Genet Genomic Med. 2014 Mar;2(2):134-7
pubmed: 24689076
Neuromuscul Disord. 2001 Jan;11(1):35-40
pubmed: 11166164
JAMA Neurol. 2015 Jun;72(6):689-98
pubmed: 25938801
Neuromuscul Disord. 2021 Oct;31(10):1038-1050
pubmed: 34736625
Ann Neurol. 2020 Apr;87(4):568-583
pubmed: 31970803
J Neuromuscul Dis. 2015 Sep 2;2(3):219-227
pubmed: 27858739
J Neurol. 2017 Oct;264(10):2053-2067
pubmed: 28669118
Neuromuscul Disord. 2021 Feb;31(2):139-148
pubmed: 33384202
Acta Myol. 2018 Jun 01;37(2):121-127
pubmed: 30057997
Neuromuscul Disord. 2011 Aug;21(8):556-62
pubmed: 21724397
Muscle Nerve. 2014 Dec;50(6):1011-6
pubmed: 25088345
Neuromuscul Disord. 2021 Jun;31(6):532-538
pubmed: 33832840

Auteurs

Luke Perry (L)

The Dubowitz Neuromuscular Centre, MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street, Institute of Child Health, Great Ormond Street Hospital, University College London, London, UK.
NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.
MRC International Centre for Genomic Medicine in Neuromuscular Diseases, London, UK.

Georgia Stimpson (G)

The Dubowitz Neuromuscular Centre, MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street, Institute of Child Health, Great Ormond Street Hospital, University College London, London, UK.

Leeha Singh (L)

The Dubowitz Neuromuscular Centre, MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street, Institute of Child Health, Great Ormond Street Hospital, University College London, London, UK.

Jasper M Morrow (JM)

Queen Square Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.

Sachit Shah (S)

Queen Square Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.

Giovanni Baranello (G)

The Dubowitz Neuromuscular Centre, MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street, Institute of Child Health, Great Ormond Street Hospital, University College London, London, UK.
NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.
MRC International Centre for Genomic Medicine in Neuromuscular Diseases, London, UK.

Francesco Muntoni (F)

The Dubowitz Neuromuscular Centre, MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street, Institute of Child Health, Great Ormond Street Hospital, University College London, London, UK.
NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.
MRC International Centre for Genomic Medicine in Neuromuscular Diseases, London, UK.

Anna Sarkozy (A)

The Dubowitz Neuromuscular Centre, MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street, Institute of Child Health, Great Ormond Street Hospital, University College London, London, UK.
MRC International Centre for Genomic Medicine in Neuromuscular Diseases, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH